<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: To determine whether patients with <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo> and true <z:hpo ids='HP_0011713'>left bundle branch block</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e>) <z:mp ids='MP_0000002'>morphology</z:mp> have better response to cardiac resynchronization therapy (CRT) than do patients without true <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e>.METHODS AND RESULTS: We defined true <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e> as conventional <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e> plus QRS duration ≥130 ms and mid-QRS notching/slurring in at least two of the leads I, aVL, V1, V2, V5, or V6 </plain></SENT>
<SENT sid="1" pm="."><plain>We prospectively enrolled 58 patients with <z:hpo ids='HP_0001635'>heart failure</z:hpo> and allocated them to three groups: true <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e> (t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e>, n = 22); non-true <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e> (nt-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e> with no notch or notches in fewer than two of the leads, n = 17); and non-specific <z:e sem="disease" ids="C0259758" disease_type="Disease or Syndrome" abbrv="">intraventricular conduction delay</z:e> (IVCD, n = 19) </plain></SENT>
<SENT sid="2" pm="."><plain>At 6 month follow-up, mean absolute increases in left ventricular ejection fraction were 16.0% ± 11.6% in t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e>, 8.1% ± 11.2% in nt-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e> (P = 0.02), and 3.3% ± 7.8% in IVCD (P &lt; 0.001, t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e> vs. IVCD) and changes in mean New York Heart Association class were -1.2 ± 0.6 in t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e>, -0.8 ± 0.6 in nt-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e> (P = 0.071), and -0.5 ± 0.6 in IVCD (P = 0.01, t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e> vs. IVCD) </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients with t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e> were responders, some were super-responders </plain></SENT>
<SENT sid="4" pm="."><plain>Multivariate analysis showed that t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e> (odds ratio, OR, 11.680; 95% confidence interval, CI, 1.966-69.390; P = 0.007) and left ventricular end-diastolic dimension (OR, 0.891; 95% CI, 0.797-0.996; P = 0.043) are independent predictors of super-response to CRT.CONCLUSION: In patients with conventional wider <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e> <z:mp ids='MP_0000002'>morphology</z:mp>, the presence of mid-QRS notching or slurring is a strong predictor of better response to CRT </plain></SENT>
</text></document>